Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase3, Recruiting
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Location: The Bronx NY, New York NY, Nashville TN, Chicago IL,
Sponsor: Imviva Bio
Sex: All
Age: 1+
Code: NCT07070219
Phase1, Phase2, Recruiting
Discovery Diabetes
for
Type 1 Diabetes
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 13 - 21
Code: NCT07116434
Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Norfolk VA, Chapel Hill NC, Grand Rapids MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase2, Phase3, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New Haven CT, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase1, Recruiting
Understanding Cognitive-Academic Bidirectionality in Math Learning Disabilities
for
Math Learning Disability
Location: Nashville TN
Sponsor: Vanderbilt University
Sex: All
Age: 6 - 8
Code: NCT07220746
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Boston MA, Providence RI, New Haven CT, The Bronx NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase3, Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Boston MA, Great Neck NY, New York NY, Montreal,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase2, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
for
Primary Sclerosing Cholangitis (PSC)
Location: Baltimore MD, Nashville TN, Iowa City IA, Seattle WA
Sponsor: LISCure Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06699121
Phase2, Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Hershey PA, Washington D.C. DC, Chapel Hill NC,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase2, Recruiting
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
for
Advanced Solid Tumor
Location: Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07751042
Phase1, Phase2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,